115 related articles for article (PubMed ID: 24801497)
41. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
Craig FF; Lackie JM; Parton R; Freer JH
J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
[TBL] [Abstract][Full Text] [Related]
42. Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion.
Mazar J; Cotter PA
Mol Microbiol; 2006 Nov; 62(3):641-54. PubMed ID: 16999837
[TBL] [Abstract][Full Text] [Related]
43. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
Ryan M; Gothefors L; Storsaeter J; Mills KH
Dev Biol Stand; 1997; 89():297-305. PubMed ID: 9272363
[TBL] [Abstract][Full Text] [Related]
44. High purity and recovery of native filamentous hemagglutinin (FHA) from Bordetella pertussis using affinity chromatography.
Imani D; Bahadori T; Golsaz-Shirazi F; Douraghi M; Jeddi-Tehrani M; Amiri MM; Shokri F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1239():124122. PubMed ID: 38669775
[TBL] [Abstract][Full Text] [Related]
45. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
46. Modulation of the infant immune responses by the first pertussis vaccine administrations.
Mascart F; Hainaut M; Peltier A; Verscheure V; Levy J; Locht C
Vaccine; 2007 Jan; 25(2):391-8. PubMed ID: 17116347
[TBL] [Abstract][Full Text] [Related]
47. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.
Locht C; Bertin P; Menozzi FD; Renauld G
Mol Microbiol; 1993 Aug; 9(4):653-60. PubMed ID: 8231801
[TBL] [Abstract][Full Text] [Related]
48. Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.
Abramson T; Kedem H; Relman DA
Infect Immun; 2001 Apr; 69(4):2650-8. PubMed ID: 11254631
[TBL] [Abstract][Full Text] [Related]
49. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.
Fedele G; Bianco M; Debrie AS; Locht C; Ausiello CM
J Immunol; 2011 May; 186(9):5388-96. PubMed ID: 21430219
[TBL] [Abstract][Full Text] [Related]
50. Effect of hydromechanical forces on the production of filamentous haemagglutinin and pertussis toxin of Bordetella pertussis.
Rodríguez ME; Samo AL; Hozbor DF; Yantorno OM
J Ind Microbiol; 1993 Feb; 12(2):103-8. PubMed ID: 7764157
[TBL] [Abstract][Full Text] [Related]
51. N-terminal characterization of the Bordetella pertussis filamentous haemagglutinin.
Lambert-Buisine C; Willery E; Locht C; Jacob-Dubuisson F
Mol Microbiol; 1998 Jun; 28(6):1283-93. PubMed ID: 9680216
[TBL] [Abstract][Full Text] [Related]
52. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
McGuirk P; Mills KH
Eur J Immunol; 2000 Feb; 30(2):415-22. PubMed ID: 10671196
[TBL] [Abstract][Full Text] [Related]
53. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
Novotny P; Chubb AP; Cownley K; Charles IG
Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
[TBL] [Abstract][Full Text] [Related]
54. Filamentous Hemagglutinin of
Golshani M; Rahman WU; Osickova A; Holubova J; Lora J; Balashova N; Sebo P; Osicka R
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293453
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies.
Leininger E; Probst PG; Brennan MJ; Kenimer JG
FEMS Microbiol Lett; 1993 Jan; 106(1):31-8. PubMed ID: 8440465
[TBL] [Abstract][Full Text] [Related]
56. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis.
Prasad SM; Yin Y; Rodzinski E; Tuomanen EI; Masure HR
Infect Immun; 1993 Jul; 61(7):2780-5. PubMed ID: 8514379
[TBL] [Abstract][Full Text] [Related]
57. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA.
Hannah JH; Menozzi FD; Renauld G; Locht C; Brennan MJ
Infect Immun; 1994 Nov; 62(11):5010-9. PubMed ID: 7927782
[TBL] [Abstract][Full Text] [Related]
58. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis.
Menozzi FD; Mutombo R; Renauld G; Gantiez C; Hannah JH; Leininger E; Brennan MJ; Locht C
Infect Immun; 1994 Mar; 62(3):769-78. PubMed ID: 8112848
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
Castro JT; Oliveira GS; Nishigasako MA; Debrie AS; Miyaji EN; Soares-Schanoski A; Akamatsu MA; Locht C; Ho PL; Mielcarek N; Oliveira MLS
PLoS One; 2020; 15(1):e0228055. PubMed ID: 31945121
[TBL] [Abstract][Full Text] [Related]
60. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.
Menozzi FD; Gantiez C; Locht C
FEMS Microbiol Lett; 1991 Feb; 78(1):59-64. PubMed ID: 2032624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
